Articles From: ABM Industries Announces 2014 Third Quarter Financial Results to Amarin to Present at the Rodman & Renshaw 2014 Global Investment Conference


ABM (NYSE:ABM) , a leading provider of facility solutions, today announced financial results for the fiscal 2014 third quarter that ended July 31, 2014.
Sign-up for ABM Industries Announces 2014 Third Quarter Financial Results investment picks
Acadia Realty Trust (NYSE:AKR), will release its third quarter 2014 earnings on Tuesday, October 28, 2014 after market close.
Sign-up for Acadia Realty Trust to Announce Third Quarter 2014 Earnings on October 28, 2014 investment picks
FIS ™ (NYSE: FIS), the world’s largest provider of banking and payments technology solutions and a global leader in consulting and outsourcing solutions, has signed a definitive agreement to acquire Brussels-based Clear2Pay.
Sign-up for Acquisition of Clear2Pay Bolsters FIS’ Enterprise Payments Portfolio investment picks
2014/9/3
Add disclaimer text after last paragraph of release.
Sign-up for ADDING and REPLACING Lazard Asset Management Launches Two Open-End Mutual Funds investment picks
2014/9/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141891&ProfileId=051205&sourceType=1 ANAHEIM, CA --
Sign-up for Advanced Defense Technologies, Inc. (ADTI) Provides Solution to the RF Transceivers for High Speed Data Links investment picks
Advanced Drainage Systems, Inc. (NYSE: WMS) (“ADS” or the “Company”), a leading global manufacturer of water management products and solutions for commercial, residential, infrastructure and agricultural applications, today announced financial results for the fiscal first quarter ended June 30, 2014.
Sign-up for Advanced Drainage Systems Announces Fiscal First Quarter 2015 Results investment picks
2014/9/3
ANN ARBOR, Mich.
Sign-up for Advanced Photonix, Inc. to Participate at Annual Liolios Group Gateway Conference investment picks
http://media.marketwire.com/attachments/201103/23230_Advant.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1140693&ProfileId=051205&sourceType=1 TOKYO, JAPAN --
Sign-up for Advantest Earns STATS ChipPAC's Outstanding Award in Service and Support for Seventh Year in a Row investment picks
CAMBRIDGE, Mass., Sept.
Sign-up for Aegerion Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference investment picks
2014/9/3
Aegion Corporation’s (Nasdaq Global Select Market: AEGN) Interim Chief Executive Officer, Charles R.
Sign-up for Aegion Corporation Interim Chief Executive Officer to Attend D. A. Davidson & Co. 13th Annual Engineering & Construction Conference investment picks
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that on August 29, dosing commenced of the first patients enrolled in the Company’s Phase 3 registration trial in Canada of Rhopressa TM , a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
Sign-up for Aerie Pharmaceuticals Inc. Initiates Phase 3 Safety-Only Registration Trial in Canada of RhopressaTM in Patients with Glaucoma investment picks
AeroVironment, Inc. (NASDAQ: AVAV) today reported financial results for its first quarter ended August 2, 2014.
Sign-up for AeroVironment, Inc. Announces Fiscal 2015 First Quarter Results investment picks
The AES Corporation (NYSE: AES) announced today that it has, through one of its subsidiaries, entered into a strategic partnership with the Estrella-Linda Group (“Estrella-Linda”), an investor group based in the Dominican Republic.
Sign-up for AES Announces Strategic Partnership for its Business in the Dominican Republic investment picks
Aetna (NYSE: AET ) and Baylor Scott & White Quality Alliance today announced an accountable care collaboration and the introduction of the Aetna Whole Health SM product in North Texas.
Sign-up for Aetna and Baylor Scott & White Quality Alliance Announce Accountable Care Collaboration in Dallas investment picks
COLUMBUS, Ohio and CHINO, Calif.
Sign-up for Affiliated Business Group and Yellow Box Corporation Announce New Store in Sherman Oaks, CA investment picks
- Akamai CEO Dr.
Sign-up for Akamai at IBC 2014: Defining the Next-Generation Content Delivery Network investment picks
Linux systems infiltrated and controlled in a DDoS botnet Entertainment industry targeted by DDoS attacks Large and growing botnet believed to be expanding from Asia to more regions CAMBRIDGE, Mass.
Sign-up for Akamai Warns of IptabLes and IptabLex Infection on Linux, DDoS attacks investment picks
2014/9/3
Fans invited to follow Russell on the road and save 10 percent on airfare* SEATTLE , Sept.
Sign-up for Alaska Airlines Offers Early Boarding for Customers Wearing Russell Wilson Jersey investment picks
Third nTelos Wireless network expansion supported by Alcatel-Lucent and will serve more than 2.1 million additional people in two East Coast states PARIS , Sept.
Sign-up for Alcatel-Lucent LTE technology selected by nTelos Wireless to support its Strategic Network Alliance with Sprint in the United States investment picks
2014/9/3
Alimentation Couche-Tard announces its results for its first quarter of fiscal year 2015 Canada NewsWire Overview of the First Quarter of Fiscal 2015 Statoil Fuel & Retail Period results Our results for the 12-week period ended July 20, 2014 include those of Statoil Fuel & Retail for the period beginning May 1 st , 2014 and ending July 20, 2014 , resulting in a period of 81 days.
Sign-up for Alimentation Couche-Tard announces its results for its first quarter of fiscal year 2015 investment picks
2014/9/3
Record net earnings of $269.5 million ( $0.47 per share on a diluted basis) for the first quarter of fiscal 2015.
Sign-up for Alimentation Couche-Tard announces its results for its first quarter of fiscal year 2015 investment picks
Sweden is latest country to grant marketing authorization ATLANTA , Sept.
Sign-up for Alimera Sciences' ILUVIEN® Receives Tenth National Marketing Authorization For The Treatment Of Chronic Diabetic Macular Edema investment picks
Alkermes plc (NASDAQ: ALKS) today announced completion of patient enrollment in a phase 2 study of ALKS 3831, an investigational, novel, oral, broad-spectrum atypical antipsychotic medicine in development for the treatment of schizophrenia.
Sign-up for Alkermes Announces Completion of Patient Enrollment in Phase 2 Study of ALKS 3831, a Novel, Broad-Spectrum Oral Antipsychotic investment picks
Allegion plc (NYSE: ALLE), a leading global provider of security products and solutions, announced that its board of directors has declared a quarterly dividend of $0.08 cents per ordinary share of the company.
Sign-up for Allegion Declares Quarterly Dividend investment picks
FORT WORTH, Texas, Sept.
Sign-up for ALLIED ELECTRONICS EARNS AS9120A CERTIFICATION investment picks
Alnylam Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2014 at 10:20 a.m. ET at the Grand Hyatt in New York City.
Sign-up for Alnylam to Webcast Presentation at Morgan Stanley Global Healthcare Conference investment picks
2014/9/3
Altria (MO) affirmed its full-year 2014 per-share profit outlook of $2.54 to $2.59. That represents growth of 7% to 9% over the tobacco company's 2013 profit of $2.38 a share.
Sign-up for Altria affirms full-year profit outlook investment picks
2014/9/3
Altria Group, Inc. (Altria) (NYSE:MO) is participating today in the Barclays Back-To-School Consumer Conference in Boston, Mass.
Sign-up for Altria Presents at the Barclays Back-To-School Consumer Conference; Reaffirms 2014 EPS Guidance investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020932-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/2/11G020932/logo-1384140982526.jpg BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - September 03, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F.
Sign-up for Amarin to Present at the Rodman & Renshaw 2014 Global Investment Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ABM Industries Announces 2014 Third Quarter Financial Results to Amarin to Present at the Rodman & Renshaw 2014 Global Investment Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices